NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

Pricing in the Market for Anticancer Drugs

David H. Howard, Peter B. Bach, Ernst R. Berndt, Rena M. Conti

NBER Working Paper No. 20867
Issued in January 2015

---- Acknowledgments ----

David H. Howard has received grant funds from Pfizer, Inc. for a project unrelated to this study. Peter B. Bach is a consultant to Foundation Medicine and has received speaking fees from Genentech, the Biotechnology Industry Organization (BIO), MPM Capital, Goldman Sachs, the Boston Consulting Group and McKinsey & Company. Ernst R. Berndt serves as an unpaid member of the Academic Advisory Panel to the IMS Institute for Healthcare Informatics. Rena M. Conti received funding from a K07 CA138906 award from the National Cancer Institute to the University of Chicago. This article is forthcoming in the Winter (February 2015) issue of the Journal of Economic Perspectives, used with permission. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page

 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us